The Latest
Geopolitics
India Rejects the Same Tribunal That Once Ruled in Its Favor
A day after a Hague tribunal ordered India to restore the Indus Waters Treaty, India rejected the ruling as illegal. The same kind of treaty tribunal ruled for India in 2013, and nobody called it illegal then.
September 1, 2026
Geopolitics
Pakistan's Food Crisis Is a Wheat Crisis, Not a Currency Crisis
In July 2026 wheat prices jumped 78 percent while chicken and eggs got cheaper, and the rupee barely moved. That is a supply shock in one crop, not the currency-driven crisis it looks like.
September 1, 2026
Business
Investment, Not Government Spending, Drove India's Growth Beat
Real GDP grew 7.8% in the June 2026 quarter, beating the RBI's own 7.0% forecast. The composition shows why: investment grew nearly three times faster than the government's own consumption spending, the slowest of the economy's three main engines.
September 1, 2026
Business
Byju's and Unacademy Show What India's Edtech Unicorns Are Actually Worth
A negotiated acquisition and a compulsory fund filing, at two different companies, both just tested what a 2021 Indian edtech valuation is actually worth today.
September 1, 2026
Health
India's Malaria Elimination Is Entering the Phase That Failed Before
Cases and deaths are down about 80 percent since 2015, and 160 districts have logged zero cases since 2022. The 33 districts still fighting the disease are the same kind of last mile India lost once before, in the decade after 1965.
September 1, 2026
Business
Subhash Chandra's Creditors Are Set to Recover Just 0.03 Percent of What They Are Owed
An NCLT order lets Subhash Chandra settle Rs 22,006 crore in debt for Rs 6.5 crore. India's personal-guarantee insolvency cases were already recovering almost nothing before his.
August 31, 2026
Business & Markets
Business
Investment, Not Government Spending, Drove India's Growth Beat
Real GDP grew 7.8% in the June 2026 quarter, beating the RBI's own 7.0% forecast. The composition shows why: investment grew nearly three times faster than the government's own consumption spending, the slowest of the economy's three main engines.
September 1, 2026
Business
Byju's and Unacademy Show What India's Edtech Unicorns Are Actually Worth
A negotiated acquisition and a compulsory fund filing, at two different companies, both just tested what a 2021 Indian edtech valuation is actually worth today.
September 1, 2026
Business
Subhash Chandra's Creditors Are Set to Recover Just 0.03 Percent of What They Are Owed
An NCLT order lets Subhash Chandra settle Rs 22,006 crore in debt for Rs 6.5 crore. India's personal-guarantee insolvency cases were already recovering almost nothing before his.
August 31, 2026
Technology & Science
Technology
China's Most Valuable Listed Firm Makes the Chip Washington Tried to Block
CXMT's stock market debut made it China's most valuable listed company, years after a US rule tried to keep it from fabricating advanced memory chips. India's flagship chip investment, by contrast, only assembles and tests memory made elsewhere.
August 30, 2026
Technology
ChatGPT Ads Reach India Three Days After Europe, Before Its Privacy Rules Bind
OpenAI turned on ChatGPT ads in India on August 27, three days after the same feature launched across Europe under a GDPR consent rule. India will not have an equivalent operative rule until mid-2027.
August 28, 2026
Technology
India's SIM Cap Can't Reach Rings That Split Connections Across Many Buyers
A new circular blocks anyone who already holds nine connections from getting a tenth. A ring that spreads its SIMs across many separate buyers, each under the limit, never trips it.
August 21, 2026
Health, Culture & Geopolitics
Health
More Indian Households Face Ruinous Medical Bills Even as Out-of-Pocket Spending Falls
National accounts show out-of-pocket health spending's share falling for eight straight years. A patient-level study of drug-resistant infections shows why that number can still miss the sharpest end of the bill entirely.
September 1, 2026
Health
India's Malaria Elimination Is Entering the Phase That Failed Before
Cases and deaths are down about 80 percent since 2015, and 160 districts have logged zero cases since 2022. The 33 districts still fighting the disease are the same kind of last mile India lost once before, in the decade after 1965.
September 1, 2026
Health
The Pancreatic Cancer Drug That Doubles Survival Costs 173 Times India's Income
Daraxonrasib nearly doubles survival in advanced pancreatic cancer and just cleared the FDA at $477,600 a year. In India, that is 173 times the average income, and most patients are diagnosed too late for it to matter anyway.
August 27, 2026